OA09.04 | Applying insights from HIV to guide the development of a T-cell vaccine for SARS-CoV-2 | Oral Abstract Session | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
OA09.05LB | Spontaneous in vivo control of HIV replication is underpinned by the cross-clade antiviral potency of HIV-specific CD8 T cells | Oral Abstract Session | Cellular immunity |
OA10.01 | Planning for success: generating an early roadmap with global stakeholders for increasing access and uptake of new biomedical prevention products in resource-limited settings: The *Biomedical Prevention Implementation C*ollaborative (BioPIC) | Oral Abstract Session | Policy and advocacy |
OA10.02 | Pathways to global access for novel HIV prevention technologies | Oral Abstract Session | Policy and advocacy |
OA10.03 | Advocates' perspectives on an efficacy trial of F/TAF as PrEP for women | Oral Abstract Session | Community engagement in prevention research |
OA10.04 | Amplifying youth voices in HIV prevention: lessons learned from a community-based adolescent health project in Durham, NC | Oral Abstract Session | Community engagement in prevention research |
OA10.05 | Associations of climate shocks, HIV, and HIV-related behaviors amongst women in Mozambique based on the 2015 Demographic Health Survey and Climate Hazards Group InfraRed Precipitation with Station Data | Oral Abstract Session | Epidemiology of HIV |
OA11.01 | The evolution of oral PrEP access: tracking trends in global oral PrEP use over time | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
OA11.02 | A multi-country investigation of Pre-Exposure Prophylaxis preferences among young people at risk of HIV in sub-Saharan Africa | Oral Abstract Session | Humoral immunity |
OA11.03 | Surveillance data from public and private primary care facilities uncover implementation successes and gaps during pre-exposure prophylaxis (PrEP) scale-up: results from the Jilinde project in Kenya | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |